WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy P. KellyChief Technology Officer2026-02-256,228$1.93
$12.02kSell
Tina M. AlbertsonChief Medical Officer2026-02-241,066$1.96
$2.09kSell
Timothy P. KellyChief Technology Officer2026-02-243,147$1.96
$6.17kSell
Ruhi Ahmad KhanChief Business Officer2026-02-246,938$1.96
$13.60kSell
Barbara G. McClungChief Legal Officer2026-02-246,938$1.96
$13.60kSell

1 of 1

CRBU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc4.73%4,690,431$7.69MInstitution
Rachel E. Haurwitz3.85%3,816,545$6.26MInsider
Vanguard Capital Management LLC3.80%3,767,228$6.18MInstitution
Fmr LLC3.35%3,323,284$5.45MInsider
Renaissance Technologies LLC2.61%2,590,497$4.25MInstitution
Kynam Capital Management LP2.52%2,503,302$4.11MInstitution
Blackrock Inc2.16%2,143,085$3.51MInstitution
Two Sigma Investments LP1.77%1,759,934$2.89MInstitution
Bank Of America Corp1.31%1,297,167$2.13MInstitution
Aberdeen Group PLC1.22%1,212,541$1.99MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU38.16%8.68%Net Selling
ABOS63.69%15.73%Net BuyingNet Selling
MIST23.93%10.86%Net SellingNet Selling
HURA14.85%33.07%
ORMP32.35%55.22%Net SellingNet Selling
View Top Biotech Stocks

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 38.16% institutional shareholders, 8.68% Caribou Biosciences insiders, and 53.16% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.82M shares representing 3.85% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $6.26M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.